These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12963994

  • 1. Automated real-time PCR to determine K-ras codon 12 mutations in non-small cell lung cancer: comparison with immunohistochemistry and clinico-pathological features.
    Hilbe W, Dlaska M, Duba HC, Dirnhofer S, Eisterer W, Oberwasserlechner F, Mildner A, Schmid T, Kühr T, Wöll E.
    Int J Oncol; 2003 Oct; 23(4):1121-6. PubMed ID: 12963994
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer.
    Spasova I, Novotna H, Vachtenheim J, Bartosova H, Patek J, Hoserova V, Zatloukal P, Kinkor Z.
    Neoplasma; 2005 Oct; 52(3):255-9. PubMed ID: 15875089
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction.
    Lehman TA, Scott F, Seddon M, Kelly K, Dempsey EC, Wilson VL, Mulshine JL, Modali R.
    Anal Biochem; 1996 Aug 01; 239(2):153-9. PubMed ID: 8811898
    [Abstract] [Full Text] [Related]

  • 7. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
    Jassem J, Jassem E, Jakóbkiewicz-Banecka J, Rzyman W, Badzio A, Dziadziuszko R, Kobierska-Gulida G, Szymanowska A, Skrzypski M, Zylicz M.
    Cancer; 2004 May 01; 100(9):1951-60. PubMed ID: 15112277
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
    Schneider PM, Praeuer HW, Stoeltzing O, Boehm J, Manning J, Metzger R, Fink U, Wegerer S, Hoelscher AH, Roth JA.
    Br J Cancer; 2000 Aug 01; 83(4):473-9. PubMed ID: 10945494
    [Abstract] [Full Text] [Related]

  • 10. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.
    Mitsudomi T, Viallet J, Mulshine JL, Linnoila RI, Minna JD, Gazdar AF.
    Oncogene; 1991 Aug 01; 6(8):1353-62. PubMed ID: 1679529
    [Abstract] [Full Text] [Related]

  • 11. High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer.
    Scott FM, Modali R, Lehman TA, Seddon M, Kelly K, Dempsey EC, Wilson V, Tockman MS, Mulshine JL.
    Clin Cancer Res; 1997 Mar 01; 3(3):479-82. PubMed ID: 9815708
    [Abstract] [Full Text] [Related]

  • 12. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA, Nemunaitis J, Scanlon KJ, Tong AW.
    Gene Ther; 2000 Dec 01; 7(23):2041-50. PubMed ID: 11175317
    [Abstract] [Full Text] [Related]

  • 13. Molecular staging of non-small cell lung cancer according to K-ras genotypes.
    Rosell R, Monzó M, Pifarré A, Ariza A, Sánchez JJ, Moreno I, Maurel J, López MP, Abad A, de Anta JM.
    Clin Cancer Res; 1996 Jun 01; 2(6):1083-6. PubMed ID: 9816271
    [Abstract] [Full Text] [Related]

  • 14. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
    Lang SM, Stratakis DF, Freudling A, Ebelt K, Oduncu F, Hautmann H, Huber RM.
    Eur J Med Res; 2000 Aug 18; 5(8):341-6. PubMed ID: 10958767
    [Abstract] [Full Text] [Related]

  • 15. Detection of activated K-ras in non-small cell lung cancer by membrane array: a comparison with direct sequencing.
    Chong IW, Chang MY, Sheu CC, Wang CY, Hwang JJ, Huang MS, Lin SR.
    Oncol Rep; 2007 Jul 18; 18(1):17-24. PubMed ID: 17549340
    [Abstract] [Full Text] [Related]

  • 16. GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis.
    Curigliano G, Ferretti G, Mandalà M, De Pas T, Calabrò MG, Solli P, Noberasc C, de Braud F.
    Anticancer Res; 2001 Jul 18; 21(5):3461-9. PubMed ID: 11848510
    [Abstract] [Full Text] [Related]

  • 17. [Detection of K-ras mutation from malignant cells in sputum with mutant-allele specific amplification (MASA) method].
    Kimura S, Fukuchi K, Takeda S, Shin S, Saito D, Akamatsu S, Himeji Y, Chen GL, Watanabe H, Takagi Y.
    Rinsho Byori; 1995 Jul 18; 43(7):718-23. PubMed ID: 7674546
    [Abstract] [Full Text] [Related]

  • 18. [Detection of point mutations of C-Ki-ras oncogene in colon cancer by PCR using specific oligonucleotide probes].
    Xu KM.
    Zhonghua Zhong Liu Za Zhi; 1992 Jul 18; 14(4):261-3. PubMed ID: 1396073
    [Abstract] [Full Text] [Related]

  • 19. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M, Linnemann U, Berger MR.
    Int J Oncol; 2004 Jun 18; 24(6):1537-44. PubMed ID: 15138598
    [Abstract] [Full Text] [Related]

  • 20. Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?
    Camps C, Sirera R, Bremnes R, Blasco A, Sancho E, Bayo P, Safont MJ, Sánchez JJ, Tarón M, Rosell R.
    Lung Cancer; 2005 Dec 18; 50(3):339-46. PubMed ID: 16139926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.